Sustainable and inclusive alternative proteins for Mediterranean diets (CIPROMED)
Official title: Circular and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)
Run by University of Bologna · NCT07553936 · Data updated 2026-11-12
This study tests whether breads and other Mediterranean foods made with alternative proteins (like cricket, spirulina, hemp, and legumes) change appetite, fullness, food choices, and metabolic markers in healthy adults and people who are overweight.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Bologna Academic / other |
| Locations | 1 site (Bologna, BO) |
| Status | Recruiting |
| Started | March 18, 2026 |
| Main results expected | October 31, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07553936 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with BMI between 18.5 and 34.9 kg/m² (normal weight through class I obesity) who can attend multiple clinic visits and consume the test products are ideal candidates.
✕Probably not a fit
People with documented allergies to insects, legumes, microalgae, shellfish, or related allergens, those with celiac disease, and pregnant or breastfeeding individuals are not eligible and would not be expected to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial uses an acute randomized crossover design in which participants attend five controlled test sessions to eat breads enriched with different alternative proteins (Acheta domesticus, spirulina, hemp, legumes) or a wheat control, with postprandial satiety, hunger, cravings, food preferences, and short-term energy intake measured after each session. Randomization follows a Latin square and is stratified by sex and weight status to allow within-subject comparisons and reduce confounding. A chronic phase applies structured Mediterranean-diet interventions incorporating prototype products (insect-enriched bread, seaweed-based burger, or control) over a longer period to observe sustained effects. Outcomes include subjective appetite measures, dietary intake, and metabolic markers to link short-term responses with longer-term eating behavior and health signals.
Why it matters
Potential benefit: If successful, the project could identify sustainable alternative-protein foods that increase fullness, help reduce energy intake, and support healthier eating patterns in the Mediterranean population.
How similar studies have gone: Some short-term human studies show that certain alternative proteins can influence satiety and metabolic signals, but evidence specifically for edible insects and microalgae is limited and results are mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Providing signed informed consent, * Being between 18 and 65 years of age, * Having a body mass index (BMI) within the normal range, defined as between 18.5 and 24.9 kg/m² or Having a body mass index (BMI) between 25.0 and 34.9 kg/m², inclusive, corresponding to the overweight category or, at most, class I obesity. Exclusion Criteria: * Positive and documented history of allergy to legumes, insects, microalgae, shellfish, mollusks, crustaceans, snails, insect venom, house dust mites, or any component (ingredient or additive) present in the food prototypes tested, or a confirmed or suspected diagnosis of Celiac Disease. * History of severe allergic reactions to any type of allergen. * Pregnancy or Breastfeeding
Where it's running
-
University of Bologna, Department of Medical and Surgical Sciences
Bologna, Bo, Italy Recruiting
Study contacts
- Principal investigator: Maria Letizia Petroni, Professor — University of Bologna
- Study coordinator: Maria Letizia Petroni, Professor
- Email: marialetizia.petroni@unibo.it
- Phone: 051/2143688
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Probiotic mix to see if it boosts fullness in adults who are overweight or have obesity
A probiotic supplement is being tested in adults aged 20-70 who are overweight or have obesity to see if it makes them feel fuller and changes gut bacteria harder after 16 weeks, compared with a placebo.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
-
Satiety After Eating Okra Flour Biscuits
This study tests whether biscuits made with mature okra flour help young adults feel fuller and affect blood markers compared with standard biscuits.
-
Probiotic Y7 cocktail to help with early Parkinson’s symptoms
A 12-week randomized trial will test whether a probiotic Y7 cocktail helps people with early Parkinson’s disease by possibly improving motor, thinking, and everyday symptoms.
-
Novel functional snack and perimenopause: does a fibre- and phytochemical-rich bite help symptoms?
A daily snack enriched with phytochemicals and fiber is being tested to see if it can reduce perimenopausal symptoms and improve well-being in women aged 40–55 who are not using hormone therapy.
-
Dairy versus plant-based yogurt effects on weight, muscle, bones, and gut bacteria
This study will test whether eating dairy yogurt instead of a plant-based yogurt (or no yogurt) helps postmenopausal women with overweight or obesity maintain muscle and bone health, control weight, and change gut bacteria.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.